In the fast-paced world of early-stage mRNA product and process development, it’s not just about ideas and innovation; it’s about how quickly and accurately you can measure your outcomes. Since those precious outcomes depend on the confidence you have in the quality and consistency of your mRNA and LNP test articles, your programs deserve appropriate analytical services. The pace and success of your programs hinge on your ability to differentiate signal from noise—and that requires quality insights.
The Analytical Edge
You can find these insights from Quality Control (QC) experts armed with cutting-edge analytical technologies. These professionals are committed to helping you underwrite your data and programmatic decisions. Investing in analytics will help shorten your journey to success, regardless of the stage, from your first experiment to your first-in-human study.
Ponder this: a robust analytics strategy minimizes rework and accelerates method qualification as you translate drug discovery to clinical studies. Who wouldn’t want that?
Here’s the cold truth: failing to implement quality control to see the whole picture never works out. With so much at stake, why wait until CGMP to implement a phase-appropriate analytical strategy? With Vernal Biosciences’ Analytical Services, you no longer have to wait. Say goodbye to the unknown, to second-guessing, and to results that don’t repeat because you’re in the dark about mRNA or LNP quality. Even if you are fortunate enough to catch poor or inconsistent purity, who can afford a second chance?
A Controlled Approach to Success
So, how do you avoid making ill-informed decisions about your program? It’s all about adopting an analytical strategy that scales with your needs while respecting your timeline and budget. Picture all the technology, equipment, and methods needed to measure quality attributes in a single location. Further envision the expertise and experience required to provide an adaptive, phase-appropriate approach to quality control at every step of the way. What you are picturing is now a reality, with Vernal Biosciences’ Analytical Services.
At Vernal Biosciences, we get it. That’s why we’ve developed dozens of analytical methods that align with USP and regulatory expectations. These qualification-ready methods are available in most cases with no adaptation or additional development needed. Don’t know what reference standard to use? Never fear—our manufacturing services has that figured out.
For instance, our recent poster on mRNA poly(A) sizing provides insights into two innovative techniques for assessing this crucial quality attribute.
The Bottom Line
If you want to stay ahead in this competitive landscape, you can’t afford to overlook the importance that deep understanding of your test article quality has on your success. The sooner you adopt a comprehensive QC strategy and begin conducting meaningful tests, the greater your confidence will be in your results. Start now to reduce risk, accelerate timelines, and ultimately succeed in your clinical trials. Make your journey faster, more informed, and more efficient with Vernal Biosciences’ mRNA and LNP Analytical Services.